Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease in which ... these mice exhibit scarring on the lung's lining (pleural side), mirroring the pathology observed in IPF patients. This ...

TCGFB, a private biotech founded by healthcare VC The Column Group, is tapping California biotech Surrozen to discover ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Idiopathic pulmonary fibrosis is a chronic, progressive, incurable lung disease, leading to irreversible lung tissue ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

Aug. 23, 2024 — A team of researchers has created a digital pathology platform based ... treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying ...

Dyspnea, the sensation of breathlessness or labored breathing, commonly occurs in patients with chronic pulmonary disease. Cystic fibrosis (CF) is an autosomal recessive disorder that affects the ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

After pathology and CT review ... Albritton FD, Kingdom TT. Cystic Fibrosis and Nasal Polyposis. MedGenMed 2(1), 2000 [formerly published in Medscape Pulmonary Medicine eJournal 4(1), 2000].

Under the terms of the agreement, Surrozen will provide antibody discovery services for a period of up to two years. TCGFB will own all TGF-β product related intellectual property. In exchange for ...

PULMONARY alveolar microlithiasis is a rare ... The diagnosis was thought to be diffuse fibrosis or hemosiderosis, but probably not Boeck's sarcoid. The patient was not seen again for 6 years ...